In line with this idea, Quatromoni et al. demonstrated that early blockade of TGF-β signaling prevented expansion of CD8+ TIL and negatively correlated with tumor volume, implying that some level of TGF-β signaling may be critical in generating CTL-mediated tumor rejection [154]. The gene discussed is CD8A; the disease is neoplasm.